Based on SpectronRx, the package provides the next advantages:
- 1.5-hour testing time, from prep to complete;
- 94 pattern capability (+ controls) per package;
- LOD (Restrict of Detection) of 1.2 copies of SARS-CoV-2 RNA/uL = 5 copies per response;
- Low laboratory footprint requirement.
The HymonSARS-CoV-2 Take a look at Equipment is a real-time RT-PCR take a look at meant for the qualitative detection of nucleic acid from the SARS-CoV-2 in higher respiratory specimens (akin to nasal, mid-turbinate, nasopharyngeal and oropharyngeal swab specimens) and bronchoalveolar lavage specimens from people suspected of COVID-19 by their healthcare supplier.
“We’re excited to contribute to the worldwide battle towards coronavirus by offering an environment friendly, real-time diagnostic PCR take a look at to detect SARS-CoV-2,” stated John Zehner, CEO of SpectronRx. “The scarcity of checks nationwide has hindered correct diagnostic evaluation of well being in our communities – we’re bringing testing to our communities, and hoping our contribution elevates the usual of prognosis and offers a transparent path of epidemiologic evaluation throughout our ongoing battle towards coronavirus.”
The PCR take a look at may be carried out on Utilized Biosystems 7500 PCR methods, offering speedy ends in a variety of healthcare settings akin to diagnostic labs and hospitals within the U.S., and may also be utilized in cell or rural environments. Testing is restricted to laboratories licensed below the Scientific Laboratory Enchancment Amendments (CLIA) of 1988, 42 U.S.C. §263a, to carry out excessive complexity checks. SpectronRx and its companion, HymonBio, count on to provide 10 million checks monthly for laboratories world wide.